Understanding COVID-19 Vaccine–Associate...

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year." Related Content: Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year 

In this week's roundup, Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Stress May Link Depression and Anxiety to Cardiovascular Disease." Related Content: Stress May Link Depression and Anxiety to Cardiovascular Disease 

In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the Wegovy Pill for Obesity" and more. Related Content: What to Know About the Wegovy Pill for Obesity 

In the November 26, 2024 issue of JACC, Dr. Valentin Fuster highlights four pivotal studies in cardiovascular research. The first explores the independent roles of social determinants of health and polygenic risk scores in coronary heart disease, while the second assesses the imp ... Show More

Infractus, accident vasculaire cérébral (AVC), embolie pulmonaire... Les maladies cardiovasculaires sont la première cause de mortalité dans le monde. Est-il possible de prévenir ces maladies qui affectent le cœur et les vaisseaux sanguins ? À quel moment doit-on faire un bilan c ... Show More

In this episode of Spoonful of Sugar, host Eishan Ashwat, a medical student at the University of Pittsburgh, dives into the essential yet often life-threatening topics of aortic aneurysms and dissections. Starting with a clinical vignette to set the stage, Eishan explores the ana ... Show More

In the September 2, 2025 JACC This Week, Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC highlights the issue. Listen here for a summary of our latest content, including new research on cognitive dysfunction in adults with congenital heart disease, a review of calcific aortic va ... Show More

The following question refers to Sections 6.1 and 7.4 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by University of Colorado internal medicine resident Dr. Hirsh Elhence, answered first by University of Chicago advanced heart failu ... Show More

More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit ... Show More

Join Harlan Krumholz, editor-in-chief of JACC, as he highlights groundbreaking cardiovascular science presented at this year's American Heart Association Scientific Sessions. From obesity-related heart failure to innovations in stroke prevention and disparities in care, this epis ... Show More

Hypotension and shock are both recognized as complications post-cardiac surgery. Some patients may develop more severe shock refractory to fluids and catecholamines. This response is also known as today's podcast episode, topic: vasoplegia after cardiac surgery. For this discussi ... Show More

<p>KYW Newsradio’s Rasa Kaye discusses aortic valve disease with Deborah Heart and Lung Center's Interventional Cardiologist Dr. Richard Kovach. The conversation includes Deborah’s team approach to identifying, managing and treating the condition, and the latest advances in Trans ... Show More